The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparison of tumor immune microenvironments (TIMEs) between primary and metastatic sites (Mets) in triple-negative breast cancer (TNBC).
 
Yuan Yuan
Consulting or Advisory Role - AstraZeneca; Diiachi; Genentech; Merck; Stemline Therapeutics; Stemline Therapeutics
Speakers' Bureau - AstraZeneca; Daiichi Sankyo/Lilly; Gilead Sciences; Merck
Research Funding - Genentech; Imugene; Merck; Novartis; Pfizer
Expert Testimony - Novartis
 
Irene Kang
Honoraria - Gilead Sciences
Consulting or Advisory Role - Caris Life Sciences; Daiichi Sankyo/Astra Zeneca; Pfizer
Travel, Accommodations, Expenses - Gilead Sciences
 
Jin Sun Bitar
Honoraria - biotheranostics
Consulting or Advisory Role - Novartis
 
Andrew A. Davis
Consulting or Advisory Role - bioTheranostics; Pfizer
 
Christie Hilton
Honoraria - CEA Clinical Education Alliance; OncLive/MJH Life Sciences; Targeted Oncology
Consulting or Advisory Role - AstraZeneca; bioTheranostics; Curio Science; Gilead Sciences; Johns Hopkins Metastatic Breast Cancer Clinic
Speakers' Bureau - AstraZeneca/Daiichi Sankyo; Daiichi Sankyo/Astra Zeneca
Travel, Accommodations, Expenses - Gilead Sciences; Gilead Sciences
 
Minxuan Huang
Employment - Tempus AI, Inc.
Consulting or Advisory Role - ZS Associates
 
Michael A. Thompson
Employment - Aurora Health Care; Tempus AI, Inc
Stock and Other Ownership Interests - Doximity; Tempus; Tryp Therapeutics
Consulting or Advisory Role - Takeda; VIA Oncology
Patents, Royalties, Other Intellectual Property - UpToDate, Peer Review for Plasma Cell Dyscrasias (Editor: Robert Kyle)
Other Relationship - Doximity
 
Jacob Mercer
Employment - Helsinn Therapeutics; QED Therapeutics; Tempus AI
Stock and Other Ownership Interests - Bridgebio
Travel, Accommodations, Expenses - Helsinn Therapeutics; Tempus AI
 
Stephen Lawrence Shiao
Research Funding - Merck
 
Eric Vail
Employment - LungLife AI
Stock and Other Ownership Interests - LungLife AI
Honoraria - Illumina; Thermo Fisher Scientific
Consulting or Advisory Role - Caris Life Sciences; Pfizer; PierianDx; Sanofi; Tempus
Speakers' Bureau - AstraZeneca; Bayer; Janssen Oncology; Lilly